mod3notesfall09carolyn.doc
TRANSCRIPT
-
8/10/2019 Mod3NotesFall09Carolyn.doc
1/30
RNSG 2432 ONLINE NOTESModule 3: Cardiac Rhythm Disorders
Carolyn Morse Jacobs, RN, MSN, ONC
Etiology/Pathophysiology of Cardiac Rhythm isord!rs
1. Normal conduction system of the heart as it relates to dysrhythmia !e"is #.
$%1&$%' ( )%'&)%3* +i 3'&- ( 3'&/ 0 no" normal conduction of heartbeat& S2, 2, 4undle of 5is etc & ho" each com#onent is re#resented on 67
Net"or8 s#eciali9ed cells and conduction #ath"ays that initiate and s#readelectrical im#ulses causin heart to beat
a. 0Cardiac muscle: uniue& enerate electrical im#ulse and contractioninde#endent of ner;ous system
b. Cardiac muscle: uniue& enerate electrical im#ulse andcontraction inde#endent of ner;ous system
c. 2bnormal cardiac rhythms< dysrhythmias'. =ro#erties of cardiac cells >able 3&1 #. )%3/
a. 2utomaticity"# s#ontaneous* 0S2 node hihest le;el automaticity
2# stimulated by ner;ous system ;ia ;aus ner;e3# sym#athetic increases rate of firin* #arasym#athetic decreases
rate4# 0cardiac cells in a$y#art of heart #acema8er cells or non&
#acema8er/ cells can ta8e on role of a #acema8er& bein
eneratin e?traneous im#ulses, called !ctopics% &'($y
cardiac m)scl! ca$ g!$!rat! a$ !l!ctrical imp)ls! a$dco$tractio$ i$d!p!$d!$t of $!r*o)s syst!m+#
b. 6?citability& ability of myocardial cells to res#ond to stimuli eneratedby #acema8er cells action #otential/&be electrically stimulated
RNSG 2432 1
-
8/10/2019 Mod3NotesFall09Carolyn.doc
2/30
c. Conducti;ity& ability to transmit im#ulse from cell to cell, orderlymanner
d. Contractility&ability of myocardial fibers to shorten in res#onse tostimulus* mechanical
e. Refractory absolute ( relati;e/ =. )%&)%$3. Cardiac (ctio$ Pot!$tial+i 3&1 #. )%3/ 0See 3 !ead 67 ;ideo 44
a. Measured in milli;olts m/, ;ertical a?is 67 #a#er, time sec/,hori9ontal a?is
b. 06lectrical acti;ity < "a;eforms on 6C7 stri#s due to ion mo;ement
across cell membranes stimulatin muscle contraction
c. =hases"# R!sti$g stat!,polari-!d stat!
a/ =ositi;e and neati;e ions alin on either side of cellmembrane* Na hih, lo"* relati;ely neati;e chare
"ithin cell* #ositi;e chare e?tracellularlyb/ Neati;e restin membrane #otential
2# Co$tractio$, d!polari-atio$0im#ortant& consider ho" meds"or8 to affect heart rhythm and #um#in action/
a/ Restin cell stimulated by chare
1/ Na ions enter cell throuh fast sodium channels'/ Calcium enter cells ;ia slo" calcium&sodium
channels
3/ Membrane less #ermeable to ions%/ Membrane #otential chane to slihtly #ositi;e
at @'A & @3A m
(5) Dysrhythmic meds as era#amil Calan,Bso#tin/ control dysrhythmia hat dru class*
ho" te?t #. )-/3# Thr!shold pot!$tial
a/ Cell more #ositi;eoint reached "hen action #otentialenerated
b/ Cause chemical reaction of Ca "ithin cell(1) 2ctin and myosin filaments slide toether&
#roduce cardiac muscle contraction
(2) Once myocardium com#letely de#olari9ed,re#olari9ation bein
4# R!polari-atio$#rotect heart muscle from s#asm, tetany/
a/ Cell return to restin, #olari9ed stateb/ +ast sodium channels close abru#tly
c/ Cell reains neati;e chare ra#id re#olari9ation/d/ Muscle contraction #roloned&slo" calcium&sodium
channels remain o#en #lateau #hase/e/ Once closed, sodiumotassium #um# restore ion
concentration & cell membrane #olari9ed aain.# R!fractory p!riod >ab 3.3 #. )%$/
a/ Myocardial cells resisti;e to stimulation* 00dysrhythmiastriered durin relati;e refractory and absolute
refractory #eriods1/ 2bsolute refractory #eriod: no de#olari9ation
can occur& from E "a;e until middle of > "a;e
2 RNSG 2432
-
8/10/2019 Mod3NotesFall09Carolyn.doc
3/30
'/ Relati;e refractory #eriod: reater than normalstimulus needed for de#olari9ation
contraction/* oes throuh 'nd half > "a;e
%. Ner;ous System Control
a. 2utonomic
"# Rate of im#ulse formation2# S#eed of conduction3# Strenth of contraction
b. =arasym#athetic ner;ous system: 00aus ner;e
1) Decreases rate
2) Slo"s im#ulse conduction3) Decreases force of contraction
c. Sym#athetic ner;ous system1/ Bncreases rate'/ Bncreases force of contraction
-. 6tioloy of ysrhythmiaa. Causes ;ary* treatment based u#on causati;e factors
b. Cardiac cells either contractile cells influencin #um#in action or#acema8er cells influencin electrical acti;ity of heart
c. +actors that trier"# 5y#o?ia
2# Structural chanes atherosclerosis, atrial fibrillation, chanesafter MB etc/
3# Electrolyte imbalanceses#ecially altered0#otassium,0calcium,0manesium, sodium le;els/
4# CNS stimulation as caffeine, nicotine, cocaine*.# !ifestyles beha;iors
# Medications 0dio?in, recall thera#eutic le;els/, beta bloc8ers&end in FlolG, drus that slo" do"n or drus that s#eed&u# heart
rate.d. Bdentify, e;aluate, treat dysrhythmia&determined by client res#onse
. Sinificance of dysrhythmias&a. Dec. cardiac out#ut and cerebralH;ascular #erfusion
b. Normal Sinus Rhythm& NSR/, atria fill, stretch ;entricles "ith about3AI more blood* 0atrial 1ic1G occurs* im#ro;es contractility of;entricles* increases cardiac out#ut. ie& if im#ulse start in 2 node or
;entricles, atrial and ;entricular contraction not coordinated* Fatrial8ic8G is lost& cardiac out#ut falls.
RNSG 2432 3
6cto#ic stimuli occurrin durinrefractory #eriod e;en by
cardio;ersion/ allo" re&entryim#ulses&cause #remature beats,abnormal conduction #, )%$
-
8/10/2019 Mod3NotesFall09Carolyn.doc
4/30
4 RNSG 2432
-
8/10/2019 Mod3NotesFall09Carolyn.doc
5/30
I$t!rpr!tatio$ of Cardiac Rhythms
1. 6C7& 7ra#hic recordin electrical acti;ity of heart'. 1'&!ead 6C7 +i 3 '(3 #. )%%/ 0Standard 1'&lead 6C7* simultaneous
recordin of limb leads and #recordial leads ;ie"s of electricalconduction/
a. Si l!adsmeasure electrical forces in frontal #lane Lim l!ads:bi#olar leads B, BB, BBB, and uni#olar leads or aumented limb leads:aR, a! and a+/
b. Si l!ads1 '3%-/ measure electrical forces in hori9ontal
#lane3. !ead =lacement& 3 leadH- lead +i 3.% #. )%-/ ( access lin8 &>heoretical
4asis for 67 ( 3 !ead 67 ;ideos&Bntroductiona. 6ach lead has #ositi;e, neati;e and round electrode
b. 6ach lead loo8s at a different area of heart.c. Can be dianostic recall MB ie S> ele;ation/
d. 4est& lead BB and MC! modified chest lead/ or 1 leads& lead BB easy tosee = "a;es. MC! or 1 easy to see ;entricular rhythms. ;ie" each
com#onent of 67. !ead BB& use "ith 3 !ead system ref 3 !ead 67
;ideo/e. Bf im#ulse oes to"ard #ositi;e electrode&com#le? #ositi;ely deflected
or u#riht
f. Bf im#ulse oes a"ay from #ositi;e electrode&com#le? neati;elydeflected or oes do"n form baseline
2ssess lin8&>heoretical 4asis for 67 ( 3 !ead 67 ;ideos& Bntroduction 0ideos
located "ith Module 3 in 4lac8board* ui9 items also in 4lac8board/ 0as8 if difficultyin locatin
EG Sta$dard L!ads 'from Th!or!tical 5asis for EC#
>hese leads& usually desinated as B, BB and BBB.
1. 4i#olar i.e., detect a chane in electric #otential bet"een t"o #oints/ anddetect an electrical #otential chane in frontal #lane.
!ead B& bet"een riht arm and left arm electrodes,& left arm bein #ositi;e.
!ead BB is bet"een riht arm and left le electrodes, leftle bein #ositi;e.
!ead BBBis bet"een left arm and left le electrodes, leftle aain bein #ositi;e.
2 diarammatic re#resentation of these three leads&
termed 6intho;enKs trianle sho"n in blue belo"/, afterDutch doctor "ho first described the relationshi#. Central
source of electrical #otential in trianle is heart.
RNSG 2432 5
http://www.technion.ac.il/~eilamp/EKGtheory.htmlhttp://www.technion.ac.il/~eilamp/EKGtheory.htmlhttp://www.technion.ac.il/~eilamp/EKGtheory.htmlhttp://www.technion.ac.il/~eilamp/EKGtheory.htmlhttp://www.technion.ac.il/~eilamp/EKGtheory.htmlhttp://www.technion.ac.il/~eilamp/EKGtheory.html -
8/10/2019 Mod3NotesFall09Carolyn.doc
6/30
EG ()gm!$t!d Lim L!ads
1. Same three leads that form standard leads also formthe three uni#olar leads& 8no"n as aumented
leads: aRriht arm/, a!left arm/ and a+left le/* also record chane in electric #otential
in frontal #lane.
'. Lni#olar leads& measure electric #otential at one #oint"ith res#ect to a null #oint one "hich doesnKt reister any
sinificant ;ariation in electric #otential durin contractionof heart/.
3. Null #oint& obtained for each lead by addin #otentialfrom the other t"o leads. +or e?am#le, in lead aR,
electric #otential of riht arm is com#ared to a null #oint"hich is obtained by addin toether the #otential of lead
a! and lead a+.
EG Pr!cordial L!ads
1. Si? uni#olar leads, each in different #osition on chest'. Record electric #otential chanes in heart in a cross sectional #lane
3. 6ach lead records electrical ;ariations that occur directly under electrode.
6 RNSG 2432
-
8/10/2019 Mod3NotesFall09Carolyn.doc
7/30
(ss!ssm!$t of Cardiac Rhythm
1. &(ss!ss cli!$t first& "hat res#onse to dysrhythmia connected to monitor/'. 67 stri# reconition: "a;eforms& reflect direction of electrical flo" "hat
seen on 67 stri#/a. =ositi;e u#"ard/ "a;eform is to"ard #ositi;e electrode
b. Neati;e do"n"ard/ "a;eform is a"ay from #ositi;e electrodec. 4i#hasic both #ositi;e and neati;e/ "a;eform sho"s #er#endicular
to #ositi;e #ole
d. Bsoelectric line straiht line/ absence of electrical acti;ity
3. Bdentify com#onents 67 0electrical #recedes mechanical/ 0>ab 3&'.)%$/
0Refer to #. )%$ >able 3&'& alues may ;ary slihtly "ith different sources&use te?t
boo8 for test #ur#osesa. = "a;e: atrial de#olari9ation and contraction< F#G , u#riht A.A&
A.1'/b. =R inter;al&time for sinus im#ulse to tra;el from S2 node to 2 node
and into bundle branches beinnin of = "a;e to beinnin of ERScom#le?/ A.1' & A.'A seconds
c. ERS Com#le?&;entricular de#olari9ation and contraction* transmissionof im#ulse throuh ;entricular conduction system 0A.A% A.1'/
secondsd. S> sement&beinnin of ;entricular re#olari9ation* end of ERS
com#le? to beinnin of > "a;e* isoelectric* 0Recall sinificance ofele;ated S> sement "ith MB A.1'/
e. > "a;e& ;entricular re#olari9ation* smooth and round, 1A mm tall*
same direction as ERS com#le?* abnormalities due to myocardial
inury or ischemia, electrolyte imbalances. 0Daner area if Fshoc8G on> "a;e
f. E> inter;al& total time ;entricular de#olari9ation and re#olari9ation*
beinnin of ERS com#le? to end of > "a;e* #roloned E>: #roloned
relati;e refractory #eriod < reater ris8 for dysrhythmias* shortenedE>: due to medications or electrolyte imbalance* 0measure E> inter;al
#rior to admin. some meds A.3% A.%3 seconds/. L "a;e& re#olari9ation of terminal =ur8ine fibers* same direction as >
"a;e* seen "ith hy#o8alemia contact healthcare #ro;ider/
RNSG 2432 7
-
8/10/2019 Mod3NotesFall09Carolyn.doc
8/30
%. Calc)lat! rat! &$o6 ho6 to do this+#. )%3&)3* fi. 3.-&3.P/
a. 6C7 "a;eforms recorded on #a#er& mar8in re#resentati;e of time8no" this/
b. 6ach small bo? < A.A% seconds sec/* one lare bo? - small bo?es/ able 3.$ #. )%P/ 0ey reference
Si$)s Rhythms ,electrical stimulus oriinates at S2 nodes
"% Si$)s 5radycardia
a. Characteristics: Sinus node fires A b#m* Normal conduction* rate
less than A b#m* rhythm reular* =: ERS: 1:1* =R inter;al: A:1' to .'A sec.* ERS com#le?: A.A% to A.1' sec
b. Clinical 2ssociationsHsinificance: normal in aerobically trained athletesand durin slee#* inc. ;aal #arasym#athetic/ acti;ity* inury or
ischemia to sinus node* inferior "all damae "ith acute MB* increasedintracranial #ressure* medications such as beta&bloc8ers and dio?in*
hy#othermia* acidosis* res#onse to carotid sinus massaec. 0>reatment: determine cause* treat if sym#tomatic, can lead to
decreased CO* use &atropi$! to i$cr!as! rat! or )s! pac!ma1!r
2% Si$)s Tachycardia
a. Descri#tion: normal conduction* e?ce#t rate reater than 1AA b#m
b. Clinical associationsHcauses: sym#athetic ner;ous system stimulation*bloc8ae ;aal acti;ity* body res#onse to #hysioloical stressors:an?iety, #ain, caffeine, hy#o;olemia, MB, heart failure, fe;er, etc
c. Clinical Manifestations: #al#itations* shortness of breath* di99iness,lead to inc. myocardial o?yen consum#tion may lead to anina
d. >reatment: eliminate cause as caffeine, adm drus to reduce heart
rate as &2dreneric bloc8ers and myocardial o?yen consum#tion,
anti#yretics to treat fe;er, analesics to treat #ain. Note&2denosine2denocard/ B (Hor bata bloc8ers may be indicated. see #. )-A/
10 RNSG 2432
-
8/10/2019 Mod3NotesFall09Carolyn.doc
11/30
3% Si$)s (rrhythmia
a. Descri#tion: normal conduction, ho"e;er irreular rhythm& rate A&1AA, increases "ith ins#iration, decreases "ith e?#iration* =, ERS,>
"a;e normalb. Clinical associationHcauses& normal in children, dru effect as MSA%/,
MB
c. >reatment& none
S)pra*!$tric)lar dysrhythmias 'atrial arrythmias/ Can be serious: atriaco$tri)t!s 2.,3=ase, dec. 2 conduction s#eed/, amiodarone Cardarone/ Class BBB #otassium
channel bloc8er/, dofetilide >i8osin/ #otassium channel bloc8er/, ;era#amil 0Calan/calcium channel bloc8ers 0 no" these
4% Pr!mat)r! (trial Co$tractio$
a. Descri#tion: atria is pac!ma1!r: P>?RS> ">"* ecto#ic atrial beatoccurs earlier than ne?t e?#ected sinus beat* = "a;e&abnormallysha#ed, or = "a;e lost in ERS* =R inter;al shorter* ERS normal A.A
to A.1'/* ha;e a non&com#ensatory #ause early beat affects = "a;ea##earance/
b. Clinical associations&due to emotional stress, caffeine, tobacco,alcohol, hy#o?ia, electrolyte imbalances, CO=D, ;al;ular disease
c. Clinical sinificance& Bsolated =2Cs ¬ sinificant if healthy hearts&heart disease may reuired trt.
RNSG 2432 11
-
8/10/2019 Mod3NotesFall09Carolyn.doc
12/30
d. >reatment&de#ends on sym#toms: &2dreneric bloc8ers to dec. =2Cs,
reduce or eliminate caffeine See #. )- >ab 3&)/
.% S)pra*!$tric)lar Tachycardia 'S@T#/Paroysmal S)pra*!$tric)lar
Tachycardia 'PS@T#, hy im#ortant Tdecreases cardiac out#ut
a. Descri#tion: oriinates in ecto#ic focus any"here abo;e bifurcation ofbundle of 5is&Rate 1-A&'-A* atria is #acema8er, may not see = "a;es
due to ra#id rate ecto#ic foci abo;e ;entricles/* Run of re#eated
#remature beats< usually =2Csb. Descri#tion contaro?ysmal& abru#t onset and termination* some
deree of 2 bloc8 may be #resent* occur in #resence of olff&=ar8inson&hite =/ syndrome
c. Clinical 2ssociations& initiated by a 0r!,!$tryA loopin or around 2node* #reci#itated by sym#athetic ner;ous system stimulation and
stressors includin fe;er, se#sis, hy#erthyroidism* heart diseasesincludin C5D, diitalis to?icity, myocardial infarction, rheumatic heart
disease, myocarditis or acute #ericarditis* cor #ulmonale, olff&=ar8inson&hite syndrome =/
d. Clinical Sinificance: #al#itations, Fracin heartG, an?iety, di99iness,dys#nea, aninal #ain, e?treme fatiue, dia#horesis, #roloned heart
rate abo;e 1)A lead to decreased CO
e. >reatment:2# &@agal stim)latio$> @alsal*a, couhin* I@ ad!$osi$!
ho" does it "or8/
3# Bf ;aal maneu;ers andHor dru thera#y ineffecti;e andHor#atient hemodynamically unstable, DC cardio;ersion needed
4# &(d!$oci$ '(d!$ocard#I@ stops h!art,& allo"s S2 node toreset brief asystole/* similar to electrical cardio;ersion* short
term use only* i;e only in BCL, 6R, monitored situations.tem#orary/* also dio?in, ;era#amil, inderal, cardia9em
ti8osyn to #re;ent recurrance.# 0=S> recurs in olff&=ar8inson&hite syndrome, may need
radiofreuency catheter ablation of accessory #ath"ay
12 RNSG 2432
http://en.wikipedia.org/wiki/Wolff-Parkinson-White_syndromehttp://en.wikipedia.org/wiki/Wolff-Parkinson-White_syndrome -
8/10/2019 Mod3NotesFall09Carolyn.doc
13/30
% (trial Bl)tt!r
a. Descri#tion: origi$at!s i$ atria from si$gl! !ctopic foc)s* ra#id,
reular atrial rhythm due to i$tra,atrial r!,!$try m!cha$ism* atrialrate '%A&3AA, ;entricular rate de#ends u#on deree of 2 bloc8,
usually 1-A 4=M* = "a;es Fsa"& toothedG, ratio ':1, 3:1, %&1*flutter "a;es* =R inter;al not measured
b. Clinical associations: C2D, hy#ertension, mitral ;al;e disorders,#ulmonary embolus, chronic lun disease, cardiomyo#athy,
hy#erthyroidism, ;al;ular diseases, =* due to sym#athetic ner;ousstimulation
c. Cli$ical Sig$ifica$c!:1/ 5ih ;entricular rates T1AA/ and loss of the atrial F8ic8G &
decrease CO ( #reci#itate 5+, anina'/ Ris8 for stro8e &ris8 of thrombus formation in the atria 0not
as bad as "ith atrial fibrillation0d. >reatment: =rimary oal& slo6 *!$tric)lar r!spo$s!by increasin
2 bloc8
1/ 7!ds to slo6 *!$tric)lar r!spo$s! as &adreneric
bloc8ers or calcium channel bloc8er follo"ed by uinidine,
#rocainamide, flecainide or amiodarone. 0>hin8 about "hy,ho" these meds "or8
'/ Sy$chro$i-!d cardio*!rsio$& con;ert the atrial flutter to
sinus rhythm emerently and electi;ely* maintain rhythm"ith antidysrhymic meds
3/ 2lation to obliterate abnormal conduction #ath"ays
% &(trial Birillatio$a. >otal disorani9ation atrial electrical acti;ity due to multi#le ecto#ic foci
lead to loss of effecti;e atrial contraction* no = "a;es, 0garag!
as!li$!A:atrial rate 3AA&AA* too ra#id to count* ;entricular rate"
-
8/10/2019 Mod3NotesFall09Carolyn.doc
14/30
b. Clinical associations: underlyin heart disease, rheumatic heart disease
heart disease, C2D, 5>N cardiomyo#athy, thyroto?icosis, caffeine use,5+, #ercarditis, Q1 arrhythmia in elderly
c. Clinical Significance: lead to d!cr!as! i$ COdue to ineffecti;e
atrial contractions loss of atrial 8ic8 and ra#id ;entricular res#onseRR/*
1/ &Thromi form in atria due to blood stasis'/ &Emol)sde;elo# and tra;el to brain cause 0stro8e
d. >reatment: 7oals&decrease ;entricular res#onse* #re;ent emboli1/ &Pr!*!$t lood clots,anti#latelet, anticoaulation* reduce
ris8 of stro8e0'/ Co$*!rt to si$)s rhythm or g!t to co$troll!d rat!
of"he
scar tissue directs electric sinals throuh a controlled #ath, orma9e, to ;entricles.
D% F)$ctio$al ysrhythmiasa. Descri#tion: 02 node& #acema8er* S2 node failed to fire or im#ulse
bloc8ed at 2 node* rate& %A&A 4=M, can ha;e unctional tachycardiaor A&1%A 4=M* = "a;e #atterns ;ary, may be absent or #recede ERS
in;erted in BB, BBB and 2+, or hidden in ERS or follo" ERS/* =Rinter;al is absent or hidden .1A* ERS normal at A.A&A.1A sec
14 RNSG 2432
http://www.webmd.com/heart-disease/atrial-fibrillation/maze-procedure-for-atrial-fibrillationhttp://www.webmd.com/hw-popup/atrial-fibrillationhttp://www.webmd.com/heart-disease/atrial-fibrillation/maze-procedure-for-atrial-fibrillationhttp://www.webmd.com/hw-popup/atrial-fibrillation -
8/10/2019 Mod3NotesFall09Carolyn.doc
15/30
b. Clinical 2ssociationsHcauses: dru to?icity Dio?in, am#hetamines,caffeine, nicotine/, hy#er8alemia, increased ;aal tone, cardiac
causes* hy#o?ia, hy#o?ia, ischemia, inferior MB, electrolyte imbalancesc. Clinical Sinificance
1/ Ser;e as safety mechanism "hen S2 node has not beeneffecti;e
'/ 6sca#e rhythms should not be su##ressed3/ Bf rhythms ra#id, may result in reduction of CO and 5+
d. >reatment often none reuired/"# If symptomatic 'slo6 rat!#, atropi$!
2# 2ccelerated unctional rhythm and unctional tachycardiacaused by dio?in to?icity&, hold dio?in
3# &2dreneric bloc8ers, calcium channel bloc8ers, amiodarone&
for control of unctional tachycardia not caused by dio?in
to?icity4# No DC cardio;ersion
(trio*!$tric)lar '(@# Co$d)ctio$ 5loc1s> Delayed or bloc8ed transmission ofsinus im#ulse throuh 2 node due to tissue inury or disease, increased ;aal tone,
dru effects
% Birst,!gr!! (@ 5loc1a. Descri#tion& 0E*!ry imp)ls! co$d)ct!d to *!$tricl!s, d)ratio$
(@ co$d)ctio$ prolo$g!d* transmission throuh (@ $od! d!lay!d.1/ ERS normal, = "a;e normal* rate: A&1AA 4=M* slo"ed
transmission throuh 2 node* =R inter;al is T A.'A
b. Clinical 2ssociations: MB, C2D, Rheumatic fe;er, hy#erthyroidism,
;aal stimulation, drus as Dio?in, &adreneric bloc8ers, calcium
channel bloc8ers, flecainide li8e #ro#afenone&Rythmol class 1C/
&Hhy th!s! dr)gs implicat!d
RNSG 2432 15
-
8/10/2019 Mod3NotesFall09Carolyn.doc
16/30
c. Clinical Sinificance1/ Lsually asym#tomatic
'/ May be pr!c)rsor to high!r d!gr!!s of (@ loc1d. >reatment
1) Chec8 medications 0 Bf on diitalis or beta bloc8ers, holdmeds
2) Continue to monitor
""J 4>"
16 RNSG 2432
-
8/10/2019 Mod3NotesFall09Carolyn.doc
17/30
b. Clinical 2ssociations* Rheumatic heart disease, C2D, 2nterior MB,Diitalis to?icity
c. Clinical Sinificance* &Progr!ss to third,d!gr!! (@ loc1*associated "ith a #oor #ronosis* reduced 5R result in dec. CO "ith
hy#otension and myocardial ischemia
d. >reatment: If symptomatice.., hy#otension, anina/ before#ermanent #acema8er, use tem#orary trans;enous or transcutaneous#acema8er* 7ay try atropi$! li8ely not to be effecti;e# J Is)pr!l
'6hy th!s! dr)gs #: lo$g t!rm,&P!rma$!$t pac!ma1!r
"2% &Third,!gr!! (@ !art 5loc1 'Compl!t! !art 5loc1#
a% Descri#tion: Borm of (@ dissociatio$, &$o imp)ls!s from atriaco$d)ct!dto ;entricles* atria stimulated, contract inde#endently of
;entricles
1/ entricular rhythm& Fesca#eG rhythm'/ 6cto#ic #acema8er &abo;e or belo" bifurcation of bundle of
5is3) 2tria and ;entricles beat inde#endently se#arate rates for
each/* rhythm from unctional fibers rate %A A 4=M/ or
;entricular 3A 4=M/* No PR i$t!r*al: 6id! ?RS
RNSG 2432 17
http://en.wikipedia.org/wiki/Artificial_pacemakerhttp://en.wikipedia.org/wiki/Artificial_pacemaker -
8/10/2019 Mod3NotesFall09Carolyn.doc
18/30
% Clinical 2ssociations: Se;ere heart disease: C2D, MB, myocarditis,
cardiomyo#athy* Systemic diseases: 2myloidosis, scleroderma* Drus:
Dio?in, &adreneric bloc8ers, calcium channel bloc8ers
c% Clinical Sinificance: fatiue, SO4, faintin* Sy$cop!from se;erebradycardia or e;en #eriods of asystole: if )$tr!at!d ,d!cr!as!d
cardiac o)tp)t a$d shoc1d% >reatment:
1) &Tra$sc)ta$!o)s pac!ma1!r )$til a p!rma$!$tpac!ma1!r
2) Drus e.., atro#ine, e#ine#hrine/: >em#orary &increase 5Rand su##ort 4= until tem#orary #acin is initiated then
#ermanent
3) =ermanent #acema8er reuired
&@ENTRICML(R SRT7I(S 'origi$at! i$ *!$tricl!s: most s!rio)s+#,Disru#tion of ;entricular rhythm& s!rio)s im#act cardiac out#ut and tissue
#erfusion. 6C7 Characteristics of ;entricular rhythms: Wide and bizarre QRS
compl! ' sement, > "a;e deflected in o##osite direction from ERS
com#le?
"3% &Pr!mat)r! @!$tric)lar Co$tractio$s '&need to recognize)
a% Descri#tion: 0Co$tractio$ origi$ati$g i$ !ctopic foc)s of*!$tricl!s% Pr!mat)r! occ)rr!$c! of a 6id! a$d distort!dJ 6id!
i-arr! ?RS compl! 'ri#let or sal;o: 3 =Cs in a ro"
4ieminy: =C e;ery other beat>rieminy: =C e;ery third beat
Lnifocal =Cs: arise from one site* all =Cs loo8 sameMultifocal =Cs: from different ecto#ic sites all =C s
loo8 different arise from different foci
2) Rate ;aries, rhythm irreular, =C interru#t underlyinrhythm* follo"ed by com#ensatory #ause* No = "a;e before
=C* no =R inter;al
3/ Due to enhanced automaticity or a re&entry #henomenon
18 RNSG 2432
-
8/10/2019 Mod3NotesFall09Carolyn.doc
19/30
% Cli$ical (ssociatio$s: Stimulants: Caffeine, alcohol, nicotine,amino#hylline, e#ine#hrine, iso#roterenol, Dio?in, electrolyte
imbalances, hy#o?ia, fe;er, disease states: MB, mitral ;al;e #rola#se,
5+, C2Dc% Clinical Sinificance: normal heart, usually benin1/ 5eart disease, =Cs may decrease CO ( #reci#itate anina
and 5+* must monitor #atient res#onse to =Cs'/ =Cs often do not enerate sufficient ;entricular contraction
to result in #eri#heral #ulse3/ 2#ical&radial #ulse rate assess to determine #ulse deficits
%/ Re#resents ;entricular irritability-/ May occur after lysis of coronary artery clot "ith thrombolytic
thera#y in acute MBUre#erfusion dysrhythmias and after#laue reduction "ith #ercutaneous coronary inter;ention
/ 0#ost MB PAI de;elo# =Cre#resent ;entricular irritability&
lead to lethal dysrhythmias @TJ @Bi gr!at!st ris1 of
d!ath+# & &&'R o$ T# ph!$om!$o$ 'P@Cs falli$g o$ T6a*!K%l!ad to fatal *!$tric)lar firillatio$+
d% Tr!atm!$t, as!d )po$ ca)s!1/ O?yen thera#y for hy#o?ia
'/ 6lectrolyte re#lacement
3/ r)gs>Class BB*&2dreneric bloc8ers as meta#rolol/* Class
I(/I5,sodi)m cha$$!l loc1!r& !idocaine, #rocainamide*#henytoin Dilantin#, "stli$! for *!$tric)lar: Class III
potassi)m Cha$$!l 5loc1!r& amiodarone/&1stline for
RNSG 2432 19
-
8/10/2019 Mod3NotesFall09Carolyn.doc
20/30
;entricular 0Must treat if reater than - =C a minute, runs of=C, multifocal =Cs See #. )- >ab 3&) 2ntidysrhythmic
meds%/ (latio$
"4% @!$tric)lar Tachycardia '@TJ @Tach#
a. Descri#tion: R)$ of thr!! or mor! P@Cs:monomor#hic,#olymor#hic, sustained, and non&sustained* life&threatenin due to
decreased CO* 00d!t!riorat! to *!$tric)lar firillatio$
1/ ra#id ;entricular rhythm of 3 or more =Cs* Rate T 1AA&'-A"ith reular rhythm* no = "a;e, ERS T.1'* "ide and bi9arre*
may occur in short bursts, runs or T 3A seconds.'/ due to re&entry #henomenon
b. Clinical 2ssociationsHcauses: electrolyte imbalance, cardiomyo#athy,
mitral ;al;e #rola#se, lon E> syndrome, diitalis to?icity, MB, dito?icity, mechanical irritability, dysfunctional F#acema8erG* MB most
common factor
c. Cli$ical Sig$ifica$c!, @T Q 0stal!A 'pati!$t has p)ls!# or0)$stal!A 'pati!$t p)ls!l!ss/
1/ S)stai$!d @T> s!*!r! d!cr!as! CO, se;ere hy#otension,"ea8 or non& #al#able #ulse, loss of consciousness,
#ulmonary edema, decreased cerebral blood flo", ;entricular
fibrillation, cardiac arrest.'/ >reatment must be ra#id, "ill recur
d% Tr!atm!$t1/ =reci#itatin causes &identify and treat e.., hy#o?ia/
'/ Monomor#hic > anda/ 5emodynamically stable e.., @ #ulse/ @ #reser;ed !
left ;entricular/ function> gi*! I@ procai$amid!JsotalolJ amiodaro$!J or lidocai$!
b/ 5emodynamically unstable or #oor ! function: gi*! I@amiodaro$! or lidocai$! follo6!d y cardio*!rsio$
3/ =olymor#hic > "ith a normal baseline E> inter;al: &
2dreneric bloc8ers, lidocaine, amiodarone, #rocainamide, or
sotalol* cardio;ersion used if dru thera#y ineffecti;e%/ =olymor#hic > "ith a #roloned baseline E> inter;al: B
manesium, iso#roterenol, #henytoin, lidocaine, or
20 RNSG 2432
http://www.schuechtermann-klinik.de/service_centre_for_patients/medical_information/treatment_of_cardiac_dysrhythmia/index_eng.htmlhttp://www.schuechtermann-klinik.de/service_centre_for_patients/medical_information/treatment_of_cardiac_dysrhythmia/index_eng.html -
8/10/2019 Mod3NotesFall09Carolyn.doc
21/30
antitachycardia #acin: stop dr)gs that prolo$g th! ?Tinter;al* cardio;ersion if rhythm does not con;ert. >orsades
de #ointes, #. )-- 3&1)/-/ &@T 6itho)t p)ls!,lif!,thr!at!$i$g sit)atio$ '$o$,
r!spo$si*!/a# Cardiop)lmo$ary r!s)scitatio$ 'CPR# a$d rapid
d!firillatio$# Epi$!phri$! if d!firillatio$ )$s)cc!ssf)l
".% @!$tric)lar Birillatio$& @Bi#Se;ere deranement of heart rhythm*
6C7 sho"s irreular undulations of ;aryin contour and am#litude& noeffecti;e contraction or CO occurs
a% Descri#tion: e?tremely ra#id, chaotic rhythm & ;entricles ui;er, do notcontract* 0cardiac arrest and death result "ithin % minutes if rhythm
not terminated* %AA&1AAA beats #er minutetoo ra#id to count
1) 7arbae baseline: $o P 6a*!sJ $o ?RSSJ NO cardiaco)tp)t
% Clinical 2ssociations: 2cute MB, C2D, cardiomyo#athy, may occurdurin cardiac #acin or cardiac catheteri9ation, "ith coronary
re#erfusion after fibrinolytic thera#y, accidental electrical shoc8,hy#er8alemia, hy#o?ia, acidosis, dru to?icity
c% Clinical Sinificance: )$r!spo$si*!J p)ls!l!ssJ ap$!ic stat!J)$tr!at!dd!ath
d% >reatment:
1/ COE sit)atio$,Bmmediate initiation of C=R and ad;ancedcardiac life su##ort 2C!S/ measures "ith immediate use ofdefibrillation and definiti;e dru thera#y
&ca$$ot cardio*!rtK$o rhythm to cardio*!rt
"% (systol!, total absence of ;entricular electrical acti;ity, no ;entricularcontraction CO/ occurs& no de#olari9ation
RNSG 2432 21
-
8/10/2019 Mod3NotesFall09Carolyn.doc
22/30
a. Descri#tion: No electrical conductionH no ;entricular acti;ity* C2RDB2Carrest, death* no rate* no F#G "a;e, or e;en if F#G "a;e, no ;entricular
res#onse* no ERS, no conduction* no rhythm
b. Cli$ical associatio$: most commonly after termination of atrial, 2
unctional or ;entricular tachycardias* usually insinificant in those
cases 0adenosinewas used to stopthese abnormal rhythms/1/ aysystole of loner duration in #resence of acute MB and C2D
freuently fatal'/ ad;anced cardiac disease, se;ere cardiac conduction system
disturbance
3/ end&stae 5+c. Clinical sinificance: unres#onsi;e, #ulseless, and a#neic state
1/ #ronosis for asystole& e?tremely #oord. >reatment
1) &CPR 6ith i$itiatio$ of (CLS m!as)r!s '!%g%J i$t)atio$Jtra$sc)ta$!o)s paci$gJ a$d I@ th!rapy 6ith
!pi$!phri$! a$d atropi$!#
"% EG cha$g!s r!lat!d to (c)t! Coro$ary Sy$drom! CS #. )1 +i3.'), 'P, 3A and >ab. 3.13/ 0Re;ie" #re;ious notes n MB
a. 6C7 chanes in res#onse to ischemia, inury, or infarction ofmyocardial cells
b. Chanes in leads that face area of in;ol;ementc. Reci#rocal o##osite/ 6C7 chanes often seen in leads facin o##osite
area in;ol;edd. =attern of 6C7 chanes& information on coronary artery in;ol;ed in
2CS
22 RNSG 2432
-
8/10/2019 Mod3NotesFall09Carolyn.doc
23/30
e. ST s!gm!$t !l!*atio$ is sig$ifica$tif T1 mm abo;e isoelectric line1/ Bf treatment #rom#t, effecti;e, may a;oid infarction
'/ Bf serum cardiac mar8ers #resent, ha;e S>&sement&ele;ationMB S>6MB/
f. =hysioloic E "a;e & first neati;e deflection follo"in = "a;e, smalland narro" A.A% second in duration/* #atholoic E "a;e is dee# and
TA.A3 second in duration. =atholoic E "a;e &at least half thic8ness of heart "all in;ol;ed E
"a;e MB/, May be #resent indefinitelyh. > "a;e in;ersion related to infarction&occurs "ithin hours* may #ersist
for months
RNSG 2432 23
-
8/10/2019 Mod3NotesFall09Carolyn.doc
24/30
P)ls!l!ss El!ctrical (cti*ity ,6lectrical acti;ity can be obser;ed on the 6C7, butthere is no mechanical acti;ity of the ;entricles and the #atient has no #ulse*
>reatment& C=R follo"ed by intubation and B e#ine#hrine* 2tro#ine is used if the;entricular rate is slo"* directed to"ard correction of the underlyin cause
S)dd!$ Cardiac !ath 'SC#, Death from a cardiac cause* maority of SCDs due
to ;entricular dysrhythmias ;entricular tachycardia, ;entricular fibrillation/
Prodysrhythmia , 2ntidysrhythmic drus may cause life&threatenin dysrhythmias
es#. Dio?in and class B2, BC, and BBB antidysrhythmia drus* first se;eral days of
dru thera#y most ;ulnerable #eriod for de;elo#in #rodysrhythmias. 0ideally bemonitored in hos#ital.
Collaorati*! Car! for ysrhythmias
"% Boc)s
a. Reconition and identification of dysrhythmia
b. 6;aluatin the effects, es#ecially lethalityc. >reatment of underlyin causesd. Nursin assessment: a#ical rate and rhythm* a#icalHradial deficit*
blood #ressure* s8in, urine out#ut, sins of decreased cardiac out#ute. Bnter;ention in dysrhythmia
1/ 2ntidysrhythmia drus'/ Defibrillation
a/ Cardio;ersion
b) Bm#lantable cardio;erter&defibrillatorc/ =acema8er
d/ Radio&freuency catheter ablation thera#y
2% ECG rhythm a$alysis proc!ss as co;ered/a. Rate determination
b. Reularity determinationc. = "a;e assessment
d. 2ssessment of = to ERS relationshi#e. Determination of inter;als
1/ =R inter;al'/ ERS com#le? duration
3/ E> inter;alf. Bdentification of abnormalities
3% iag$ostic T!sts as co;ered&see also #. $-3&$-- >ab 3'&$/a% "2 l!ad El!ctrocardiogram
1/ Bdentification of rhythm'/ Bnformation about underlyin disease #rocesses
3/ Monitor effects of treatment
% Cardiac St)di!s re;ie" all/1/ Continuous cardiac monitorin
'/ 2mbulatory 6C7 monitorin 5olter monitorin or>ranstele#honic e;ent recorder/
3/ 6?ercise >readmill test
24 RNSG 2432
-
8/10/2019 Mod3NotesFall09Carolyn.doc
25/30
%/ 6chocardiocram HStress echocardioramH=harmacoloic 6C5O"hat dru/
-/ >ranseso#haeal 6chocardioram >66// Nuclear Cardioloy includin #harmacoloical nuclear imain
"hat dru/ ML72, =6>$/ MR2, MRB
)/ Cardiac Catheteri9ation etc
I$t!r*!$tio$s/Th!rapy for ysrhythmia
"% !firillatio$6merency deli;ery of direct current 6itho)t r!gard to cardiac cycl!
'*!$tric)lar firillatio$#: #erformedimm!diat!ly"hen rhythmreconi9ederformed e?ternally or internally surery, o#en chest/* also
automatic e?ternal Defibrillators. 00Note "here #addles are #laced =, )-$fi 3&'P&Read te?t
a% !firillatio$ &$o$,r!spo$si*!J p)ls!l!ss cli!$t
1/ Most effecti;e method &terminate + and #ulseless >'/ =assae of DC electrical shoc8 throuh heart to de#olari9e cells
of myocardium to allow SA nodeto resume role of #acema8er3/ Deli;er enery usin a mono#hasic or bi#hasic "a;eform
Mono#hasic Deli;er enery one direction* bi#hasic deli;erenery t"o directions successful shoc8s at lo"er eneries,
fe"er #ostshoc8 6C7 abnormalities/%/ O)tp)t,measured in;o)l!s/6atts#er second
% Recommended enery for initial shoc8s1/ 4i#hasic +irst and successi;e shoc8s: 1-A to 'AA oules
'/ Mono#hasic&Bnitial at 3A oules3/ 2fter initial shoc8, chest com#ressions C=R/
2% Sy$chro$i-!d Cardio*!rsio$
Direct electrical current synchroni9ed "ith heart rhythm: a*oid shoc1 d)ri$g*)l$!ral! p!riod of r!polari-atio$ 'R o$ T#
El!cti*! proc!d)r!,tr!at S@TJ a,fiJ fl)tt!rJ h!mody$amically stal!@T
0Cli!$ts i$ afi-; need anticoagulation several wees beforecardioversion, dec. ris8 for thromboembolism #ost cardio;ersion
RNSG 2432 25
http://en.wikipedia.org/wiki/Cardioversionhttp://en.wikipedia.org/wiki/Cardioversion -
8/10/2019 Mod3NotesFall09Carolyn.doc
26/30
1/ Choice of thera#y for hemodynamically unstable ;entricular or
su#ra;entricular tachydysrhythmias
2) Synchroni9ed circuit &deli;ers countershoc8 on R "a;e of ERScom#le? of 6C7
3) Synchronizer switch must be turned on
3% Impla$tal! Cardio*!rt!r, !firillator'IC# 0ho is a candidate for
one & read #. )-$P)ls! g!$!rator impla$t!dsurically into client "ith lead electrodes forrhythm detection and current deli;ery* senses rate and "idth of ERS,
combined #acema8er* senses life&threatenin rhythm chanes* deli;ersautomatic electric shoc8 to con;ert dysrhythmia
a! +or clients "ho sur;i;ed SCD Sudden cardiac death/b! 5a;e s#ontaneous sustained >, synco#e "ith >, fib durin 6=S
c! 2t hih ris8 for future life&threatenin dysrhythmias;"#f fires$ contacthealth care %rovider$ or &''(
d! Consists of lead system #laced ;ia subcla;ian ;ein to endocardiume! 4atteryo"ered #ulse enerator im#lanted subcutaneously
f! #C) sensing system- monitors *R and rhythm$ identifies +, or+
g! 2##ro?. '- sec. after detectin > or +, BCD deli;ers '- oules* iffirst shoc8 unsuccessful, BCD recycles and deli;ers successi;e shoc8s
h! 6ui##ed "ith antitachycardia and antibradycardia #acema8ersi! Bnitiates o;erdri;e #acin of S> and >
.! =ro;ides bac8u# #acin for bradydysrhythmias! 6ducation critical* fear, body imae alteration, an?iety, su##ort rou#
/"See ,ab 01-2 %! 2324
26 RNSG 2432
1. =ro;ides #acin on demand
'. Stores 6C7 records of rhythms3. Can be re#rorammed at bedside "hen
necessary
%. Needs to be surically re#laced e;ery -years
http://www.nhlbi.nih.gov/health/dci/Diseases/icd/icd_all.htmlhttp://www.nhlbi.nih.gov/health/dci/Diseases/icd/icd_all.html -
8/10/2019 Mod3NotesFall09Carolyn.doc
27/30
4% Pac!ma1!rs 'Bndications & >ab 3&1A #. )-P/0=ulse enerator, pro*id!s !l!ctrical stim)l)s to h!art 6h!$ h!art fails
to g!$!rat! or co$d)ct o6$ at a rat! for ad!9)at! cardiac o)tp)t
a. Lsed to #ace heart "hen normal conduction #ath"ay damaed ordiseased*
1/ =acin circuit consists of #o"er source, one or more conductin
#acin/ leads and myocardium'/ 6lectrical sinal stimulus/ tra;els from #acema8er, throuh
leads to "all of myocardium* myocardium Fca#turedG
&stimulated to contract
3) Bnitially for sym#tomatic bradydysrhythmias* no"antitachycardia and o;erdri;e #acin antitachycardia
#acin
-
8/10/2019 Mod3NotesFall09Carolyn.doc
28/30
Clic8 for more #acema8er information3/ Pac!ma1!rs see +i 3&'% #. )-P/
a/ Modes: aynchronousreset time "ithout fail or
synchronous or demand&"hen heart rate oes belo" setrate
b/ Sense acti;ity in and #ace ;entricles only
c) 0Most no" sense acti;ity in and #ace both atria and;entricles atrio&;entricular seuential #acin stimulatesin seuence that imitates normal seuence of atrial
contraction follo"ed by ;entricular contraction/%/ Cardiac r!sy$chro$i-atio$ th!rapy 'CRT#>=acin techniue
a/ Resynchroni9es& cardiac cycle by #acin both ;entricles
b/ Combined CR> "ith an BCD for ma?imum thera#yc/ &Importa$t for h!art fail)r! ma$ag!m!$t
-/ ECG charact!ristics +i 3.3, )-)/
a/ Paci$g d!t!ct!dby #resence of #acin artifact&0sharp spi1! occur before = "a;e in atrial #acin or
before ERS com#le? in ;entricular #acinb/ Ca#ture noted by contraction of chamber follo"in the
s#i8e seen as = "a;e in atrial #acin or ERS com#le? in;entricular #acin/
/ >eachinSee >ab 3&1' #. )1/ 0Read carefully
a# Pr!,op* teach, e?#lain #rocedure* #lace electrodes a"ay
from #otential incision site* teach ROM e?ercises for affectedsite& hel# #re;ent shoulder stiffness.
28 RNSG 2432
http://www.heartpoint.com/pacerintro.htmlhttp://www.hrspatients.org/patients/treatments/resync.asphttp://www.heartpoint.com/pacerintro.htmlhttp://www.hrspatients.org/patients/treatments/resync.asp -
8/10/2019 Mod3NotesFall09Carolyn.doc
29/30
b/ Post Qop&c hest ?&ray* mi$imi-! mo*!m!$t of aff!ct!darmdurin initial #ost&o# #eriod&decrease ris8 of
dislodin #acer* monitor #acer "ith 6C7* re#ort failure to#ace, etc* assess for dysrhythmia, ta8es '&3 days for
FseatinG* document* date of #acer insertion, model etc.
a) om! Car!: ho" it "or8s, ho" #laced, battery
re#lacement, ho" to ta8e and record #ulse, incision sitecare, acti;ity restrictions, BD card, dont hold certainelectrical de;ices near itsets off security de;ices
b) 7ai$tai$i$g saf!ty* =re;entin infection andcom#lications
.% Cath!t!r (latio$Th!rapy 'Clic1 h!r! for *id!o#6lectrode&ti##ed ablation catheter FburnsG accessory #ath"ays or ecto#ic
sites in atria, 2 node, andHor ;entriclesa. No$pharmacologic tr!atm!$tfor 2 nodal reentrant tachycardia,
re&entrant tachycardia related to accessory by#ass tracts* control of;entricular res#onse of certain tachydysrhythmias
b. Com#lete ablation of 2 node or bundle of 5is& may be done in somecases of uncontrolled ;entricular res#onse in atrial fibrillation or flutter
unres#onsi;e to medical thera#y1/ I$*ol*!s locatio$/d!str)ctio$ ')r$ !ctopic path6ay# of
!ctopic foci i$ h!art&'/ iag$os!d i$ !l!ctrophysiology la/p!rform!din cardiac
cath lab
3/ Cardiac mappi$g: identification of sites "here im#ulseinitiated in atria or ;entricles&use internal or e?ternal catheters
%/ (latio$: destroy ecto#ic focus "ithradiofreuency enery "ith
catheters* 0anticoaulant thera#y may be started after"ard todecrease ris8 of clot formin at ablation site
% Oth!r m!as)r!s to stop dysrhythmias&Bor S@T
a. &@agal ma$!)*!rs, client Fbears do"nG: forced e?halation aainst a
closed lottis to slo" heart rateb. Carotid sinus massage$continuous monitorin& by #hysician onlyc. 7!dicatio$ssuch as ad!$osi$!J calci)m cha$$!l loc1!rs
d. 0See antidysrhtymic meds 8no"/ >ab 3.) #. )- and >ab. 3%&1' #.)AA and #. $P)&)A1 and list of meds as included.
N)rsi$g Car!1. Decrease ris8 for C5+HDec. CO, "hich is maor ris8 for dysrhythmias
RNSG 2432 29
http://my.clevelandclinic.org/heart/services/tests/procedures/ablation.aspxhttp://heartdisease.about.com/cs/heartfailure/a/CHF1.htmhttp://www.webmd.com/heart-disease/treating-arrhythmias-ablationhttp://my.clevelandclinic.org/heart/services/tests/procedures/ablation.aspxhttp://heartdisease.about.com/cs/heartfailure/a/CHF1.htmhttp://www.webmd.com/heart-disease/treating-arrhythmias-ablation -
8/10/2019 Mod3NotesFall09Carolyn.doc
30/30
'. Reduce sym#athetic ner;ous system stimulants li8e caffeine
N)rsi$g iag$os!s1. 0!cr!as!d Cardiac O)tp)t
a. 2l"ays assess the client before treatin the dysrhythmiab. Monitor ;ital sins, 6C7, and o?yen saturation freuently durin
antidysrhythmic dru infusionsc. Nurses carin for clients "ith dysrhythmias& need to be com#etent in
C=R and 2C!S
'. Bneffecti;e >issue =erfusion
3. 2n?iety and fear%. no"lede deficit